In the era of effective antiretroviral therapy (ART), liver disease is the second most common
cause of death among persons with human immunodeficiency virus (HIV) infection. Liver …

Abstract Background Abnormal liver enzymes (LFTs) are frequently seen in HIV patients.
Because HCV and HBV overshadow other possible variables, little is known about the …

Hepatic steatosis has been reported in human immunodeficiency virus (HIV)/hepatitis C
virus (HCV) coinfection. However, the features of steatohepatitis, including cytologic …

BACKGROUND/AIMS: Hepatic steatosis is caused by the complex interaction of host and
viral factors, such as metabolic syndrome (MS), alcoholism and HCV genotype, and in HIV …

Background and aims Patients with HIV and hepatitis C virus (HCV) coinfection are at
increased risk of developing hepatic steatosis. The aims of this study were to assess the …

Background Liver steatosis is a common finding in hepatitis C virus (HCV) infection and is
associated with an increased progression of the disease. However, HCV genotype 3 …

Liver disease is a major health problem for individuals with a history of injection drug use.
This is mainly from the hepatitis C virus (HCV), with or without co-infection with HIV. HCV …

The aim of this study was to examine the incidence and factors associated with the severity
of liver fibrosis in 234 coinfected patients in Brazil. Patients were cared for in our clinic, from …

Background: The association of fat distribution with alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) elevations is not well-defined in HIV-infected individuals …

Hepatitis C virus (HCV) is an important factor contributing to morbidity and mortality in
patients co-infected with HIV and HCV. In addition, liver biopsy is an important tool in the …